3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Am J Hematol
          American journal of hematology
          Wiley
          1096-8652
          0361-8609
          December 2019
          : 94
          : 12
          Affiliations
          [1 ] Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
          [2 ] Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
          [3 ] Department of research and development, Geno-Immue Medical Institute, Shenzhen, China.
          [4 ] School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
          [5 ] Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, Florida.
          Article
          10.1002/ajh.25630
          31489688
          8f6443f7-9af1-48e6-aa38-5de7f9640a72
          History

          Comments

          Comment on this article